Smad7 has been found to interfere with TGF-β-mediated expression of TM4SF5 expression, EGFR pathway activation and subsequent EMT in both normal hepatocytes and HCC cell lines [132]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.